BRCA2 and neoplasm: In HR-proficient tumours, synthetic lethality can also be induced by combining PARP1-i with a local treatment of mild hyperthermia [5, 6, 10–15], which causes degradation of BRCA2 for several hours [13] and thereby HR deficiency at the heated tumour site.